Sélectionner une page




Menu
Close

Clinical Trials

Mobile Application

CTMA provides French innovative digital solutions aiming at facilitating patient recruitment in clinical studies, using current patients’ conditions and powerful build-in algorithms.




Get a demo

Our Mission

http://chicken-flavor.fr/wp-content/uploads/2022/07/video-mission-site-web.mp4

Some numbers

The drug development landscape is increasingly complex and competitive, with a high pressure on the time to market.

  • TOTAL R&D

  • Figure: Total R&D/clinical trials pipeline size, by year 2000-2022

    They are so many drugs in development that it is extremely challenging to finds the way to one of them, as a patient or as a site, or to secure a high visibility on one of them for a Sponsor.

    CT-SCOUTTM and ToTem4me facilitate the match between the patients and the studies.


  • Recruitment failure

  • 0
    %

    Of studies fail to meet patient recruitment deadlines

    However, millions of patients visit clinical sites every day. 

    CT-SCOUT™ help investigators identify the ones that could benefit from a clinical study.

  • Patient interest

  • 0
    %

    OF THE PATIENTS WOULD WELCOME THE OPPORTUNITY TO PARTICIPATE TO A CLINICAL STUDY

    Patients have become actors of their treatment conditions. 

    ToTem4me help them identify potential opportunities through clinical studies.

  • Patient opportunities

  • 0
    %

    of the patients are being offered to participate to a clinical study

    But 80% of patients would accept to participate t a clinical study. 

    CT-SCOUT™ contributes to increase the percentage of patients considered for clinical research.

  • Set-up time

  • 0

    Weeks set-up time

    No more than 2 weeks are required to get CT-SCOUT™

    or ToTem4me deployed for a clinical study

     

Figure: Total R&D/clinical trials pipeline size, by year 2000-2022

They are so many drugs in development that it is extremely challenging to finds the way to one of them, as a patient or as a site, or to secure a high visibility on one of them for a Sponsor.

CT-SCOUTTM and ToTem4me facilitate the match between the patients and the studies.


0
%

Of studies fail to meet patient recruitment deadlines

However, millions of patients visit clinical sites every day. 

CT-SCOUT™ help investigators identify the ones that could benefit from a clinical study.

0
%

OF THE PATIENTS WOULD WELCOME THE OPPORTUNITY TO PARTICIPATE TO A CLINICAL STUDY

Patients have become actors of their treatment conditions. 

ToTem4me help them identify potential opportunities through clinical studies.

0
%

of the patients are being offered to participate to a clinical study

But 80% of patients would accept to participate t a clinical study. 

CT-SCOUT™ contributes to increase the percentage of patients considered for clinical research.

0

Weeks set-up time

No more than 2 weeks are required to get CT-SCOUT™

or ToTem4me deployed for a clinical study

 

Our Solutions

We have customized digital solutions for the different contributors to the clinical research efforts.


CT-SCOUT

The missing link between sponsor & sites


ToTem4me

The web application to reach your matching studies


DaaS

Coming soon

CT-SCOUT™

The missing link between sponsor & sites

A multi-device application based on a unique algorithmic model to enable all physicians to quickly detect in real-time, the clinical studies running at their sites, for which a patient is potentially eligible according to his/her current health conditions.


Find out more

  • Doctor using a digital tablet computer in hospital. Healthcare A

ToTem4me

The web application for patients

A multi-device application based on a unique algorithmic model, to enable patients, with the direct support of an expert-coordinator, to quickly detect the clinical studies running in 


Find out more

DaaS Solution

Our teams are currently working on a Data solution, we will keep you informed shortly.

Testimonials

« CT-SCOUT™ represents a true added value to clinical research. It takes only few minutes to operate and study information is updated very quickly »
Prof Stéphane Nancey
Prof Stéphane NanceyHepato-gastroenterology department,
Lyon-Sud University Hospital

« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels »
ECCO Congress
Prof Laurent Peyrin-Biroulet,
Prof Laurent Peyrin-Biroulet
Prof Laurent Peyrin-BirouletPresident, GETAID and ECCO
Précédent
Suivant

News

You can follow CTMA on Twitter, LinkedIn, and Instagram, but here below you can find an extract of the recent company news !




CTMA IS MEMBERS OF THE FRANCE BIOTECH!


juin 10, 2022

CTMA is proud to announce that we have become members of the France BioTech. Click here on the link below to read …




CTMA AU SALON MEDINTECHS!


juin 10, 2022

Nous avons le Plaisir de vous annoncer que CTMA sera présente au salon MedInTech le 9 mars prochain, qui se tiendra au …




CTMA AT THE “ 10E JOURNÉE DE RECHERCHE CLINIQUE”


juillet 2, 2021

CTMA will be participating at the “ 10e Journée de Recherche Clinique” tomorrow Thursday 15th.Our CEO, Pierre Pellier will pitch for CTMA during an “Elevator …





Site mapContact

  • + 33 1 48 03 47 84
  • 13, Place Kossuth 75009 Paris

Social


Linkedin


Twitter